Innovodigm Raises Seed Funding to Revolutionize Vaccine Delivery

Funding Details and Investors

The seed funding round was led by the IAN Group, contributing Rs 4.5 crore, with PadUp Ventures investing the remaining amount.

Expansion Plans

Innovodigm plans to utilize the funds for process optimization and infrastructure development, with the goal of expanding its reach across India and other low- and middle-income countries (LMICs).

The company aims to adapt its patch technology for various vaccines, including measles, hepatitis, and flu.

The Vaccine Patch Advantage

Innovodigm's vaccine patch offers a needle-free and potentially more accessible method of vaccine delivery, especially in resource-constrained settings. Learn more about vaccine patch technology.

Future Outlook

With this new funding, Innovodigm is poised to make a significant impact on global health by improving vaccine access and delivery. This investment underscores the growing interest in innovative drug delivery systems.